Table 2.
Stimulatory effects of Wnt5a during CRC development.
| Factor | Wnt5a expression level | Wnt5a function | Mechanism | CRC sample type | Reference |
|---|---|---|---|---|---|
| TAM | High | Oncogenic | Stimulation of cell proliferation and migration through activation of CaMKǀǀ-ERK signaling | HCT116, DLD1, and tissue | [59] |
| Autocrine effect of Wnt5a | High | Oncogenic | Inducing cell proliferation, migration, and invasion via stimulation of M2 polarization of TAM and enhancing secreted IL-10 in TAMs as well as activation of CaMKǀǀ-ERK1/2-STAT3-mediated IL-10-secreting TAMs | HCT116, DLD1 | [60] |
| TrpC5 | High | Oncogenic | Decreasing differentiation and increasing stemness CRC cells by upregulation of Wnt5a and β-catenin | SW480, HT-29, SW620, DLD1, HCE8693, and RKO | [62] |
| DSS-induced CAC | High | Oncogenic | Overexpression of Wnt5a, Ror2, Fzd-2, and -5 induced by DSS lead to promote survival and proliferation through increasing CAMK2γ and activation of STAT3 signaling | IEC | [63] |
| FOXM1 | High | Oncogenic | Inhibition of maturation phenotypes and functions of BMDCs by increasing FOXM1 H3K79me2 demethylation-induced activation of Wnt5a signaling | BMDC | [64] |